文献速递精神分裂症与精神病性障碍儿童青少年精神心境障碍

22q11.2缺失或重复个体的精神障碍风险:丹麦全国注册研究

Risk of Psychiatric Disorders Among Individuals With the 22q11.2 Deletion or Duplication: A Danish Nationwide, Register-Based Study.
PubMed 文献 · JAMA Psychiatry · 2017-01-01

结果显示缺失和重复均显著增加任何精神障碍风险(IRR分别为4.24和4.99),且智力障碍风险极高(IRR分别为34.08和33.86);缺失还增加广泛性发育障碍(IRR 9.45)和儿童孤独症(IRR 8.94)风险。

要点

  • 22q11.2缺失或重复个体任何精神障碍风险均显著升高,IRR分别为4.24和4.99。
  • 缺失者智力障碍风险IRR 34.08,重复者IRR 33.86。
  • 缺失者广泛性发育障碍和儿童孤独症风险也显著增加。

核心结论

  • 22q11.2缺失或重复个体发生精神障碍的风险显著增加。

研究设计与样本

  • 采用巢式病例对照设计估计缺失或重复的指标及累积发病率,并用生存分析比较风险。

主要发现

  • 临床识别22q11.2缺失244人(男124人,50.8%),重复58人(男29人,50.0%)。
  • 任何精神障碍诊断的平均(SD)年龄:缺失者12.5(8.3)岁,重复者6.1(0.9)岁。
  • 父母精神分裂症诊断与22q11.2缺失相关,其他精神疾病诊断与重复携带状态相关。
  • 缺失者任何精神障碍IRR 4.24(95%CI 3.07-5.67),重复者IRR 4.99(95%CI 1.79-10.72)。
  • 缺失者智力障碍IRR 34.08(95%CI 22.39-49.27),重复者IRR 33.86(95%CI 8.42-87.87)。

临床怎么用

  • 对22q11.2缺失或重复个体应加强症状监测和早期临床干预。
  • 遗传咨询中可参考上述风险估计,辅助临床筛查和评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Microdeletions and duplications have been described at the 22q11.2 locus. However, little is known about the clinical and epidemiologic consequences at the population level. OBJECTIVE: To identify indicators of deletions or duplications at the 22q11.2 locus and estimate the incidence rate ratios (IRRs) and absolute risk for psychiatric disorders in clinically identified individuals with 22q11.2 deletion or duplication. DESIGN, SETTING, AND PARTICIPANTS: A Danish nationwide register study including all individuals recorded in the Danish Cytogenetic Central Register with a 22q11.2 deletion or duplication was performed. A total of 3 768 943 individuals born in Denmark from 1955 to 2012 were followed up during the study period (total follow-up, 57.1 million person-years). Indicators of 22q11.2 deletion or duplication and cumulative incidences were estimated using a nested case-control design that included individuals from the population-based cohort. Survival analysis was used to compare risk of disease in individuals with and without the 22q11.2 deletion or duplication. The study was conducted from May 7, 2015, to August 14, 2016. EXPOSURE: The 22q11.2 deletion or duplication. MAIN OUTCOMES AND MEASURES: Indicators for carrying a 22q11.2 deletion or duplication, IRR, and cumulative incidences for psychiatric diagnoses (International Statistical Classification of Diseases and Related Health Problems, 10th Revision, codes F00-F99), including schizophrenia-spectrum disorders, mood disorders, neurotic stress-related and somatoform disorders, and a range of developmental and childhood disorders. RESULTS: Among the 3 768 943 participants, 244 (124 [50.8%] male) and 58 (29 [50.0%] male) individuals were clinically identified with a 22q11.2 deletion or duplication, respectively. Mean (SD) age at diagnosis of any psychiatric disorder was 12.5 (8.3) years for individuals with deletions and 6.1 (0.9) years for duplication carriers. A parental diagnosis of schizophrenia-but not of other psychiatric diagnoses-was associated with a 22q11.2 deletion, and parental psychiatric diagnoses other than schizophrenia were associated with duplication carrier status. Both the 22q11.2 deletion (IRR, 4.24; 95% CI, 3.07-5.67) and duplication (IRR, 4.99; 95% CI, 1.79-10.72) was associated with increased risk of any psychiatric disorders. Furthermore, a highly increased risk of intellectual disability was found for the deletion (IRR, 34.08; 95% CI, 22.39-49.27) and duplication (IRR, 33.86; 95% CI, 8.42-87.87). Furthermore, individuals with the 22q11.2 deletion had an increased risk of several psychiatric disorders under study, for example, pervasive developmental disorders (IRR, 9.45; 95% CI, 5.64-14.69) and childhood autism (IRR, 8.94; 95% CI, 3.21-19.23). CONCLUSIONS AND RELEVANCE: Individuals with the 22q11.2 deletion or duplication have a significantly increased risk of developing psychiatric disorders. Survival analysis of persons carrying either the 22q11.2 deletion or duplication provides estimates of direct clinical relevance useful to assist clinical ascertainment, genetic counseling, guidance of symptomatic monitoring, and early clinical intervention.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Hoeffding LK, Trabjerg BB, Olsen L, et al. Risk of Psychiatric Disorders Among Individuals With the 22q11.2 Deletion or Duplication: A Danish Nationwide, Register-Based Study. JAMA Psychiatry. 2017. PMID: 28114601. doi:10.1001/jamapsychiatry.2016.3939

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。